Skip to main content

2022 CTOS Annual Meeting Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

Peter Reichardt, MD, PhD (he/him/his)

Head, Department of Oncology and Palliative Care
Helios Klinikum Berlin-Buch, Germany

Poster(s):

(P 315) A RANDOMIZED, PLACEBO-CONTROLLED, PHASE 2 TRIAL OF INBRX-109 IN UNRESECTABLE OR METASTATIC CONVENTIONAL CHONDROSARCOMA